🇺🇸 Losartan and Amlodipine in United States

12 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Intentional Overdose — 2 reports (16.67%)
  2. Shock — 2 reports (16.67%)
  3. Cataract — 1 report (8.33%)
  4. Extra Dose Administered — 1 report (8.33%)
  5. Headache — 1 report (8.33%)
  6. Hip Fracture — 1 report (8.33%)
  7. Limb Injury — 1 report (8.33%)
  8. Nervousness — 1 report (8.33%)
  9. Product Quality Issue — 1 report (8.33%)
  10. Radiculopathy — 1 report (8.33%)

Source database →

Other Cardiovascular approved in United States

Frequently asked questions

Is Losartan and Amlodipine approved in United States?

Losartan and Amlodipine does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Losartan and Amlodipine in United States?

Centro Universitario de Ciencias de la Salud, Mexico is the originator. The local marketing authorisation holder may differ — check the official source linked above.